Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Spotlight on P2Y2 agonists: a new target for cystic fibrosis

May 6, 1998

Surfaxin as ARDS treatment enters phase II/III

May 5, 1998

Nebulized furosemide beneficial in patients with acute asthma of short-term duration

May 4, 1998

AxyS Pharmaceuticals' APC-366 shows good antiasthmatic activity in phase IIa trial

May 1, 1998

New PDE IV inhibitors for asthma reported by Celltech

April 30, 1998

Astra obtains rights from Takeda to develop TxA2 antagonist

April 30, 1998

U.K. market introduction for long-acting, nonsedating antihistamine

April 29, 1998

Sepracor completes norastemizole trial; additional studies planned

April 29, 1998

Glaxo Wellcome launches Flovent for pediatric asthma in U.S.

April 28, 1998

Glaxo Wellcome seeks approval for combination asthma product

April 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...